BIRAX (the Britain Israel Research and Academic Exchange Partnership) is a £multi-million initiative of the British Council and the British Embassy in Israel, together with the Pears Foundation, investing in world-leading research jointly undertaken by scientists in Britain and Israel.
BIRAX Ageing has so far been supporting seven research projects at a total of £2.8, studying the link of ageing to cardiovascular disease, diabetes and bone fragility, Alzheimer’s disease development, macular disease and more. The second call for proposal was launched in late 2021.
The next call will be be announced in our newsletter.
The BIRAX Regenerative Medicine Initiative (RMI) had committed almost £8 million to 19 cutting edge projects directly involving over 100 researchers in both countries from 2011 to 2020. The projects pioneer techniques using stem cell and regenerative medicine therapies to tackle some of the world’s most challenging conditions and diseases, including cardiovascular and liver disease, diabetes, and Parkinson’s.
BIRAX operates across three strands:
- Funding cutting-edge research collaboration: BIRAX Ageing funds distinguished collaborative research projects tackling various aspects of ageing and its impact on human health. Projects are selected via rigorous biannual call for proposals system.
- Providing engagement opportunities: BIRAX is committed to providing leading scientists ample engagement opportunities including conferences, workshops, social and promotional events and meetings with fellow colleagues, senior stakeholders and other organizations that support scientific activity and exchange.
- Supporting research mobility through travel grants: BIRAX provides travel grants for early career and senior researchers to take up fellowships, lectureships and symposia.